CVRx (CVRX) Capital Expenditures Growth (1y) (2021 - 2026)
CVRx (CVRX) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -11.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -47.73% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 106.98% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn | 7.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.02% |
| Dec 31, 2025 | 30.77% |
| Sep 30, 2025 | 697.30% |
| Jun 30, 2025 | -70.99% |
| Mar 31, 2025 | -87.57% |
| Dec 31, 2024 | -69.23% |
| Sep 30, 2024 | -5.13% |
| Jun 30, 2024 | 148.25% |
| Mar 31, 2024 | 282.08% |
| Dec 31, 2023 | 113.92% |
| Sep 30, 2023 | -85.23% |
| Jun 30, 2023 | 191.84% |
| Mar 31, 2023 | -18.09% |
| Dec 31, 2022 | -85.32% |
| Sep 30, 2022 | 60.00% |
| Jun 30, 2022 | -87.07% |
| Mar 31, 2022 | 190.10% |
| Dec 31, 2021 | 432.67% |
| Sep 30, 2021 | 39.83% |